Stimcell Energetics (STME) Net Income towards Common Stockholders Growth (5y) (2021 - 2024)
Stimcell Energetics (STME) Net Income towards Common Stockholders Growth (5y) (2021 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 36.32% |
| Feb 29, 2024 | -19.30% |
| Nov 30, 2023 | -20.07% |
| Aug 31, 2023 | -18.35% |
| May 31, 2022 | 17.59% |
| Feb 28, 2022 | 16.57% |
| Nov 30, 2021 | 6.58% |
| Aug 31, 2021 | 2.57% |
| May 31, 2021 | 10.63% |
| Feb 28, 2021 | 9.57% |